$8.24
-0.23 (-2.72%)
Open$8.25
Previous Close$8.47
Day High$8.25
Day Low$7.96
52W High$11.90
52W Low$6.47
Volume—
Avg Volume17.5K
Market Cap52.18M
P/E Ratio—
EPS$-1.54
SectorBiotechnology
Analyst Ratings
Strong Buy
5 analysts
Price Target
+506.1% upside
Current
$8.24
$8.24
Target
$49.94
$49.94
$27.43
$49.94 avg
$65.11
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 32.14M | 12.59M | 12.91M |
| Net Income | -25,731,300 | -1,338,243 | -1,683,285 |
| Profit Margin | -80.1% | -10.6% | -13.0% |
| EBITDA | -29,700,823 | -1,969,871 | -1,762,148 |
| Free Cash Flow | — | -1,414,748 | -1,276,245 |
| Rev Growth | — | -1.9% | -7.4% |
| Debt/Equity | — | 1.05 | 0.93 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |